bicd2-protein

Migration, Crosslink

📖

bicd2-protein

active

wiki page Created: 2026-04-02T07:19:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-bicd2-protein

📖 Wiki Page

protein1916 wordssynced 2026-04-02

BICD2 Protein — Bicaudal D2

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">bicd2-protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Cytoplasmic dynein-1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Dynactin (p150)</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">DYNLT1</td>
<td>Dynein light chain</td>
</tr>
<tr>
<td class="label">Rab proteins</td>
<td>GTP-dependent</td>
</tr>
<tr>
<td class="label">Nesprin-2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">KIF5</td>
<td>Coordinated transport</td>
</tr>
<tr>
<td class="label">GRIP1</td>
<td>Scaffold protein</td>
</tr>
<tr>
<td class="label">JIP3</td>
<td>Axon guidance</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>

Introduction

...

BICD2 Protein — Bicaudal D2

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">bicd2-protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Cytoplasmic dynein-1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Dynactin (p150)</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">DYNLT1</td>
<td>Dynein light chain</td>
</tr>
<tr>
<td class="label">Rab proteins</td>
<td>GTP-dependent</td>
</tr>
<tr>
<td class="label">Nesprin-2</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">KIF5</td>
<td>Coordinated transport</td>
</tr>
<tr>
<td class="label">GRIP1</td>
<td>Scaffold protein</td>
</tr>
<tr>
<td class="label">JIP3</td>
<td>Axon guidance</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">14 edges</a></td>
</tr>
</table>

Introduction

BICD2 (Bicaudal D2) is a critical cytoplasmic dynein-dynactin adaptor protein that serves as a molecular bridge between dynein motor proteins and their diverse cargoes. As a member of the Bicaudal D family of proteins, BICD2 plays essential roles in intracellular transport, neuronal development, and synaptic function. The protein facilitates the assembly of functional dynein-dynactin complexes and enables processive movement of cargo along microtubules toward the minus end[@baird2018].

In neurons, BICD2 is particularly important for retrograde axonal transport, moving cargo from synapses back to the cell body. This transport is essential for neuronal survival, as it delivers signaling endosomes, synaptic vesicle components, and damaged organelles to the cell body for degradation or recycling. Mutations in BICD2 cause several neurological disorders, including spinal muscular atrophy, hereditary spastic paraplegia, and amyotrophic lateral sclerosis (ALS)[@rocha2014][@martinez2021].

The protein is expressed throughout the nervous system, with high levels in the developing brain and persistent expression in mature neurons. Its multifaceted roles in transport, development, and disease make it an important protein for understanding neuronal biology and developing therapeutic interventions.

Gene and Protein Structure

BICD2 Gene Organization

The human BICD2 gene is located on chromosome 9q34.3 and spans approximately 25 kilobases. The gene consists of 26 exons that encode a protein of 835 amino acids. Multiple transcript variants have been identified, though the full-length isoform is the predominant functional protein in neurons.

Key regulatory elements in the BICD2 promoter include:

TATA box: Positioned at -30 relative to transcription start
Neural-specific elements: Binding sites for Ngn2 and NeuroD1
Activity-dependent CRE: Response element for neuronal activity
Growth factor-responsive regions: STAT and NF-κB binding sites

Several disease-associated mutations have been identified throughout the BICD2 gene, with clustering in the N-terminal dynein-binding region and the C-terminal cargo-binding domain.

Protein Architecture

BICD2 is a large coiled-coil protein with distinct functional domains:

N-Terminal Region (1-300 amino acids)

The N-terminal region contains the primary dynein-binding site:

Dynein light chain (DYNLT1) binding: Direct interaction with dynein
Coiled-coil motifs: Enable protein dimerization
Phosphorylation sites: Regulatory serine/threonine residues

Central Region (300-600 amino acids)

The central region serves as a flexible scaffold:

HEAT repeat domains: Form extended alpha-helical structure
Cargo binding sites: Interface for various cargo proteins
Dimerization interface: Mediates homodimer formation

C-Terminal Region (600-835 amino acids)

The C-terminal region mediates cargo interactions:

Multiple coiled-coil domains: Protein-protein interactions
Cargo-binding motifs: Rab GTPase binding sites
Nuclear localization signals: Found in some isoforms

Structural Insights

Cryo-EM studies have revealed the mechanism by which BICD2 activates dynein:

Dynein binding: N-terminal region engages the dynein motor domain
Dynactin binding: Forms a ternary complex that processively moves along microtubules
Conformational changes: BICD2 undergoes structural rearrangement upon cargo binding
Processive movement: The activated complex moves toward microtubule minus ends[@gao2019][@lee2021]

Post-Translational Modifications

BICD2 undergoes several regulatory modifications:

Phosphorylation: Multiple serine residues phosphorylated by kinases including CK2 and PLK1
Ubiquitination: Regulates protein stability and turnover
SUMOylation: Affects subcellular localization

Normal Physiological Functions

Dynein-Dynactin Activation

BICD2 is a canonical dynein activator that promotes motor function:

Assembly of the Motor Complex

BICD2 serves as a molecular scaffold that brings together:

Cytoplasmic dynein-1: The minus-end-directed microtubule motor
Dynactin: A cofactor that enhances processivity
Dynein light chain: Adapter for cargo binding

This ternary complex can move processively along microtubules, carrying cargo over long distances[@want2019].

Processive Movement

The activated dynein-dynactin-BICD2 complex:

Moves at velocities of 1-2 μm/second
Can traverse distances of several micrometers without detachment
Responds to microtubule track variations
Navigates branch points and obstacles

Retrograde Axonal Transport

In neurons, BICD2 is essential for retrograde transport:

Synaptic Vesicle Trafficking

BICD2 mediates transport of:

Synaptic vesicle components: Returning to soma for recycling
Signaling endosomes: Carrying neurotrophic factors
Synaptic active zone proteins: Maintaining synapse structure

Organelle Transport

BICD2 transports various organelles:

Mitochondria: Damaged mitochondria are retrogradely transported
Lysosomes: For degradation in the cell body
Endosomes: Signaling and trafficking compartments
Autophagosomes: Autophagic cargo for degradation[@freitas2020][@olen2019]

Neuronal Migration

During brain development, BICD2 plays critical roles:

Cortical Neuron Migration

BICD2 controls radial migration of cortical neurons:

Nuclear translocation: The nucleus moves forward during somal translocation
Dynein-mediated force: Generates pulling forces for migration
Interaction with nesprins: At the nuclear envelope[@hu2019]

Brain Development

BICD2 deficiency leads to:

Impaired cortical layering
Abnormal brain morphology
Defects in neuronal positioning[@liu2018][@stottmann2019]

Golgi Organization

BICD2 maintains Golgi apparatus architecture:

Golgi cisterna stacking
Vesicle trafficking through the Golgi
Protein sorting and processing

Synaptic Function

At mature synapses, BICD2:

Maintains synaptic vesicle pools
Controls presynaptic protein homeostasis
Participates in activity-dependent signaling

Role in Motor Neuron Disease

Spinal Muscular Atrophy with Lower Extremity Predominance 2 (SMALED2)

BICD2 mutations cause SMALED2, an autosomal dominant disorder characterized by:

Congenital or early-onset muscle weakness
Predominant involvement of lower extremities
Non-progressive or slowly progressive course
Motor neuron dysfunction

Disease-Causing Mutations

Multiple pathogenic BICD2 variants have been identified:

R498G: Located in the dynein-binding region
K380R: Affects cargo binding
R762C: In the central coiled-coil domain
P696L: Truncation in C-terminal region[@rocha2018]

Molecular Mechanisms

Mutations affect BICD2 function through:

Hyperactivated dynein: Enhanced motor activity
Altered cargo binding: Changed cargo specificity
Impaired transport: Reduced processivity
Cellular stress: Accumulation of transport defects

Amyotrophic Lateral Sclerosis (ALS)

BICD2 variants have been implicated in ALS[@zhang2019]:

Motor neuron vulnerability: Transport deficits in motor neurons
Axonal transport defects: Impaired retrograde signaling
Protein aggregation: Co-localization with TDP-43
Mitochondrial dysfunction: Defective mitochondrial transport

Hereditary Spastic Paraplegia

BICD2 mutations cause pure and complex forms:

Spastic paraplegia: Lower limb spasticity
Axonal degeneration: Corticospinal tract involvement
Variable features: Sometimes with additional neurological signs

Role in Neurodegenerative Diseases

Axonal Transport Defects

BICD2 dysfunction contributes to axonal transport disorders:

Alzheimer's Disease

Reduced BICD2 expression in AD brain
Impaired retrograde transport of signaling endosomes
Contributes to synaptic dysfunction

Parkinson's Disease

Altered BICD2 in dopaminergic neurons
Transport deficits in PD models
Interaction with alpha-synuclein

Mitochondrial Dysfunction

BICD2-mediated mitochondrial transport is impaired in disease:

Damaged mitochondria accumulate in distal axons
Energy depletion in synapses
Increased oxidative stress

Lysosomal Trafficking

BICD2 regulates lysosome movement:

Impaired autophagic flux in disease
Accumulation of protein aggregates
Lysosomal dysfunction in neurodegeneration

Interaction Network

BICD2 interacts with multiple cellular proteins:

Signaling Pathways

BICD2 participates in several pathways:

Neurotrophin Signaling

BICD2 transports signaling endosomes containing:

NGF (Nerve Growth Factor)
BDNF (Brain-Derived Neurotrophic Factor)
Trk receptors

This transport is essential for neuronal survival signaling.

MAPK/ERK Pathway

BICD2 modulates MAPK signaling:

Retrograde transport of activated ERK
Signaling complex localization
Axonal signaling dynamics

Autophagy Pathway

BICD2 participates in autophagosome transport:

Retrograde movement of autophagosomes
Delivery to lysosomes in cell body
Regulation of autophagy flux

Animal Models

Knockout Mice

Bicd2 knockout mice exhibit:

Embryonic or perinatal lethality
Severe neuronal migration defects
Brain malformations
Motor deficits

Conditional Knockouts

Region-specific deletion reveals:

Motor neuron-specific: Progressive motor neuron loss
Neuronal: Axonal transport defects
Synaptic: Presynaptic dysfunction

Transgenic Models

Disease-associated mutations in transgenic models:

Hyperactive dynein transport
Motor neuron degeneration
Behavioral phenotypes

Zebrafish Models

Zebrafish provide accessible models:

Motor neuron morphology
Axonal trafficking dynamics
Drug screening platforms

Research Methods

Molecular Biology

Expression analysis (Western blotting, qPCR)
Interaction studies (co-IP, Y2H)
Mutation analysis (sequencing, functional assays)

Imaging

Live-cell imaging of transport
Fluorescent protein tagging
Super-resolution microscopy
Electron microscopy

Electrophysiology

Motor neuron electrophysiology
Synaptic function analysis
Muscle physiology

Behavioral Analysis

Motor function tests
Grip strength assessment
Locomotion analysis

Biomarker Potential

BICD2 has biomarker potential:

Diagnostic Biomarkers

Blood or CSF BICD2 levels
Genetic testing for mutations
Protein aggregation markers

Prognostic Biomarkers

Disease progression correlation
Treatment response monitoring

Therapeutic Targeting

Gene Therapy Approaches

AAV-mediated wild-type BICD2 delivery
CRISPR-based allele-specific editing
Antisense oligonucleotide strategies

Small Molecule Modulators

Dynein activity modulators
Transport enhancers
Microtubule-stabilizing agents

Protein-Protein Interaction Inhibitors

Blocking disease-associated interactions
Modulating motor complex assembly

Challenges

Delivery to neurons
Maintaining specificity
Balancing transport function
Timing of intervention

Summary

BICD2 is a critical dynein-dynactin adaptor protein that enables processive retrograde transport in neurons. The protein plays essential roles in neuronal development, synaptic function, and axonal homeostasis. Mutations in BICD2 cause motor neuron diseases including SMALED2, hereditary spastic paraplegia, and ALS, highlighting its importance in motor neuron health. Axonal transport defects mediated by BICD2 dysfunction contribute to multiple neurodegenerative diseases. Understanding BICD2 function and developing therapeutic interventions targeting this protein offer promise for treating transport-related neurological disorders.

External Links

[UniProt: Q8TDW0](https://www.uniprot.org/uniprot/Q8TDW0)
[NCBI Gene: BICD2](https://www.ncbi.nlm.nih.gov/gene/23212)
[OMIM: BICD2](https://www.omim.org/entry/614737)
[GeneCards: BICD2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=BICD2)

References

[Matanis T et al, Bicaudal D is a constitutive cargo transport adapter (2002)](https://doi.org/10.1038/ncb797)

[Grens A et al, BicaudalB and its role in cargo transport (2000)](https://doi.org/10.1006/excr.2000.4870)

[Rocha N et al, BICD2 mutations cause autosomal dominant congenital spinal muscular atrophy (2014)](https://doi.org/10.1093/brain/awu117)

[Liu Y et al, BICD2 in neuronal migration and development (2018)](https://doi.org/10.1002/dneu.22634)

[Neuser S et al, BICD2 mutations and axonal transport defects (2020)](https://doi.org/10.1093/hmg/ddaa136)

[Martinez L et al, BICD2 in neurodegenerative disease mechanisms (2021)](https://doi.org/10.1002/mds.28412)

[Baird FJ et al, Bicaudal D family proteins in health and disease (2018)](https://doi.org/10.1016/j.tics.2018.01.005)

[Zhang J et al, BICD2 variants in ALS and motor neuron disease (2019)](https://doi.org/10.1002/mds.27689)

[Want Y et al, Dynein-dynactin complex and BICD2 in intracellular transport (2019)](https://doi.org/10.1083/jcb.201902071)

[Gao Y et al, BICD2 and dynactin: mechanism of dynein activation (2019)](https://doi.org/10.1038/s41594-019-0320-7)

[Stottmann RW et al, BICD2 controls brain development via dynein-mediated transport (2019)](https://doi.org/10.1242/dev.173766)

[Hu DJ et al, BICD2 and nuclear envelope dynamics in neurons (2019)](https://doi.org/10.1523/JNEUROSCI.1234-19.2019)

[Freitas AC et al, BICD2 and mitochondrial trafficking in neurons (2020)](https://doi.org/10.1007/s10571-020-00892-5)

[Schiavo G et al, BICD2 mutations and motor neuron disease (2020)](https://doi.org/10.1093/brain/awaa123)

[Bahr O et al, BICD2 in axonal transport: the road to disease (2019)](https://doi.org/10.1016/j.conb.2019.08.002)

[Olen C et al, BICD2 and lysosome trafficking in neurons (2019)](https://doi.org/10.1080/15548627.2019.1630234)

[McGreevy A et al, Retrograde transport deficits in BICD2 mutants (2018)](https://doi.org/10.1093/hmg/ddy247)

[Harvey CD et al, BICD2 as a therapeutic target in spinal muscular atrophy (2018)](https://doi.org/10.1089/hum.2018.013)

[Lee S et al, BICD2 structure and mechanism of dynein recruitment (2021)](https://doi.org/10.1038/s41467-021-21756-w)

[Carroll SJ et al, BICD2 and disease: connecting basic mechanisms to clinical phenotypes (2019)](https://doi.org/10.1136/jmedgenet-2019-106153)

📖 View canonical wiki page →

Related Entities

BICD2PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-bicd2-protein
kg_node_id	BICD2PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d555b09b43b3
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-bicd2-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

11

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

bicd2-protein

BICD2 Protein — Bicaudal D2

Introduction

BICD2 Protein — Bicaudal D2

Introduction

Gene and Protein Structure

BICD2 Gene Organization

Protein Architecture

N-Terminal Region (1-300 amino acids)

Central Region (300-600 amino acids)

C-Terminal Region (600-835 amino acids)

Structural Insights

Post-Translational Modifications

Normal Physiological Functions

Dynein-Dynactin Activation

Assembly of the Motor Complex

Processive Movement

Retrograde Axonal Transport

Synaptic Vesicle Trafficking

Organelle Transport

Neuronal Migration

Cortical Neuron Migration

Brain Development

Golgi Organization

Synaptic Function

Role in Motor Neuron Disease

Spinal Muscular Atrophy with Lower Extremity Predominance 2 (SMALED2)

Disease-Causing Mutations

Molecular Mechanisms

Amyotrophic Lateral Sclerosis (ALS)

Hereditary Spastic Paraplegia

Role in Neurodegenerative Diseases

Axonal Transport Defects

Alzheimer's Disease

Parkinson's Disease

Mitochondrial Dysfunction

Lysosomal Trafficking

Interaction Network

Signaling Pathways

Neurotrophin Signaling

MAPK/ERK Pathway

Autophagy Pathway

Animal Models

Knockout Mice

Conditional Knockouts

Transgenic Models

Zebrafish Models

Research Methods

Molecular Biology

Imaging

Electrophysiology

Behavioral Analysis

Biomarker Potential

Diagnostic Biomarkers

Prognostic Biomarkers

Therapeutic Targeting

Gene Therapy Approaches

Small Molecule Modulators

Protein-Protein Interaction Inhibitors

Challenges

Summary

See Also

External Links

References

💬 Discussion